<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Basic and Clinical Neuroscience Journal</title>
<title_fa>مجله علوم اعصاب پایه و بالینی</title_fa>
<short_title>BCN</short_title>
<subject>Medical Sciences</subject>
<web_url>http://bcn.iums.ac.ir</web_url>
<journal_hbi_system_id>137</journal_hbi_system_id>
<journal_hbi_system_user>journal137</journal_hbi_system_user>
<journal_id_issn>2008-126X</journal_id_issn>
<journal_id_issn_online>2228-7442</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.32598/bcn</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1399</year>
	<month>10</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2021</year>
	<month>1</month>
	<day>1</day>
</pubdate>
<volume>12</volume>
<number>1</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>The Factors Associated With Olfactory Dysfunction in Patients with Multiple Sclerosis</title>
	<subject_fa>Clinical Neuroscience</subject_fa>
	<subject>Clinical Neuroscience</subject>
	<content_type_fa>Original</content_type_fa>
	<content_type>Original</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p style=&quot;margin: 0px 0px 16px; line-height: 150%;&quot;&gt;&lt;strong&gt;Introduction&lt;/strong&gt;: An impaired sense of smell has a remarkable impact on the quality of life. It is seen in a variety of neurodegenerative diseases such as Parkinson disease. In this study, we assessed the olfactory function in patients with Multiple Sclerosis (MS) by Sniff Magnitude Test (SMT).&amp;nbsp;&lt;br&gt;
&lt;strong&gt;Methods&lt;/strong&gt;: A cross-sectional study was conducted on 48 patients with MS. A questionnaire, including demographic and clinical variables, was completed for each patient. The SMT was used for the evaluation of olfactory function.&amp;nbsp;&lt;br&gt;
&lt;strong&gt;Results&lt;/strong&gt;: Olfactory dysfunction was found in 14.6% of patients (8.3% hyposmia and 6.3% anosmia). Older age, longer disease duration, higher hospital admission rate, lower mini-mental status examination score, and secondary progressive course of MS were significantly related to olfactory dysfunction.&amp;nbsp;&lt;br&gt;
&lt;strong&gt;Conclusion&lt;/strong&gt;: Secondary progressive MS and markers of advanced disease toward neurodegenerative phase (including older age, longer disease duration, and lower cognitive function) can be associated with olfactory dysfunction in MS patients.&lt;/p&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Smell, Olfaction disorders, Anosmia, Multiple Sclerosis, Secondary Progressive Multiple Sclerosis</keyword>
	<start_page>89</start_page>
	<end_page>94</end_page>
	<web_url>http://bcn.iums.ac.ir/browse.php?a_code=A-10-1368-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Mostafa</first_name>
	<middle_name></middle_name>
	<last_name>Almasi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>A_mostafa108@yahoo.com</email>
	<code>13700319475328460031844</code>
	<orcid>13700319475328460031844</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Neurology, Firouzgar Hospital, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mohammad Ali</first_name>
	<middle_name></middle_name>
	<last_name>Sahraian</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>sahraian1350@yahoo.com</email>
	<code>13700319475328460031845</code>
	<orcid>13700319475328460031845</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Fahimeh</first_name>
	<middle_name></middle_name>
	<last_name>Haji  Akhoundi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>fhakhoundi@yahoo.com</email>
	<code>13700319475328460031846</code>
	<orcid>13700319475328460031846</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Neurology, Firouzgar Hospital, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Hamid Reza</first_name>
	<middle_name></middle_name>
	<last_name>Ezzati</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>hreezzati@gmail.com</email>
	<code>13700319475328460031847</code>
	<orcid>13700319475328460031847</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Neurology, Hazrat Rasool Hospital, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Mohammad</first_name>
	<middle_name></middle_name>
	<last_name>Rohani</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>mohammadroohani@gmail.com</email>
	<code>13700319475328460031848</code>
	<orcid>13700319475328460031848</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Neurology, Hazrat Rasool Hospital, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
